Previous Close | 9.05 |
Open | 9.28 |
Bid | 0.00 x 800 |
Ask | 10.00 x 1100 |
Day's Range | 8.87 - 9.67 |
52 Week Range | 7.80 - 23.21 |
Volume | |
Avg. Volume | 275,641 |
Market Cap | 612.548M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 0.11 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Today we will run through one way of estimating the intrinsic value of Enfusion, Inc. ( NYSE:ENFN ) by estimating the...
Shares of Enfusion (NYSE: ENFN), a software-as-a-service company, were falling hard today after the company reported its fourth-quarter results. Enfusion beat Wall Street's consensus estimate for revenue in the quarter but missed analysts' earnings expectations. Enfusion reported revenue of $31.9 million for the fourth quarter, a 41% increase from the year-ago quarter and higher than the $30.4 million analysts were expecting.
(Bloomberg) -- FTV Capital, a firm focused on growth-equity bets, has raised $2.3 billion for its largest fund to date.Most Read from BloombergLow-Priced Omega Speedmaster Prompts Global Swatch Store ChaosUkraine Update: Negotiators Set for Face-to-Face Talks This WeekWill Smith Smacks Chris Rock, Wins Oscar in Wild Academy AwardsVanguard Stumbles In Pivot From Cult of Jack BogleEl Salvador Declares State of Emergency as Gang Murders SoarThe firm, which has offices in San Francisco and New York,